📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation. (2024)

First Author: Bhatt SP

Attributed to: An integrated epidemiological approach to understanding the relationship between lung health and multi-morbidity funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa2401304

PubMed Identifier: 38767614

Publication URI: http://europepmc.org/abstract/MED/38767614

Type: Journal Article/Review

Volume: 390

Parent Publication: The New England journal of medicine

Issue: 24

ISSN: 0028-4793